3rd Annual TRDRP Smoking Cessation Day-Virtual 3/5/21
Tobacco-Related Disease Research Program (TRDRP)
Fri, March 5, 2021
8:00 AM – 12:30 PM PST
https://www.eventbrite.com/e/3rd-annual-trdrp-smoking-cessation-day-virtual-3521-tickets-137994397959?utm_campaign=Trainings%20and%20Webinars&utm_medium=email&_hsmi=110843068&_hsenc=p2ANqtz–k8kTtB3gXgxdo0Qo3kICEnn2WYvLtbtGCHB5gtPsU5bjUz0E-20IHKsv4UBsimjomD4lmghBuZHfzHnPKJ-V2wakZbw&utm_content=110843068&utm_source=hs_email
About this Event
UPON COMPLETION PARTICIPANTS WILL BE ABLE TO:
- Describe nationwide efforts and resources for implementing evidence-based tobacco treatment into clinical care
- Understand the current status of California’s law about flavored tobacco products and potential population impact
- Cite biological and epidemiological evidence and health promotion strategies for smoking and COVID
- Develop a plan for implementing evidence-based tobacco treatment in various clinical settings
AGENDA
7:15 – 8:00 am – Zoom Opens
8:00 – 8:30 am – Welcome & Summary – TRDRP Efforts for Smoking Cessation 3 Research Projects. Explanation of CME and CE Processes Theodore C. Friedman, MD, PhD – CDU, Norma Mtume, MHS, MA MFT, Friends ResearchInstitute, Joseph R. Guydish, PhD
– UCSF, Elisa Tong, MD – UCD
8:30 – 9:15am -Smoking Cessation as the Fourth Pillar of Cancer Care: Lessons from the NCI’s Moonshot Cancer Center Cessation Initiative (C3I) Program Michael
C. Fiore, MD, MPH Director of the Center for Tobacco Research and Intervention, Professor of Medicine, University
of Wisconsin
9:15 – 9:20 am – Break
9:20 -10:20 am – California’s Law to Restrict the Sale of Flavored Tobacco Products: The Tobacco Industry Referendum and Impact on Community Health (Panel)
- California’s Law and the Tobacco Industry Referendum – Jim Knox, American Cancer Society Cancer
Action Network - Menthol and the African American Community – Valerie Yerger, MA, ND, UCSF
- Vaping and Youth/Young Adults – Bonnie Halpern-Felsher, PhD Stanford University
10:20- 10:25 am – Break
10:25 – 11:25 am – Quit for COVID: Why and How (Panel)
- How Smoking Worsens COVID-19 Infection in the Airways – Brigitte Gomperts, MD (UCLA)
- Smoking Associated with COVID-19 Progression – Stan Glantz, PhD, retired UCSF
- ‘Quit for COVID’ with the California Smokers’ Helpline – Elisa Tong, MD, UCD
11:25- 11:30 am – Break
11:30 –12:30 pm – Helping Others to Quit (Breakout Session)
- Trainings for Clinics and Behavioral Health Staff in Your County – Cathy McDonald, MD – Alameda
County ATOD Tobacco Dependence Treatment Training Program - Smoking Cessation Pharmacotherapy – Brian Hurley, MD, MBA, DFASM – Friends Research Institute
and Los Angeles County Department of Health Services - Group Behavioral Therapy for Smoking Cessation – Tasha Dixon, LMFT – Friends
Sponsored by Tobacco-Related Disease Research Program, National Cancer Institute, L.A. County Health Agency, UC Davis Health,
UC San Diego School of Medicine, UCLA Integrated Substance Abuse Program, California Smokers Helpline, Charles Drew
University of Medicine and Science, UCSF, and Friends Research Institute
Credits Available:
Continuing Medical Education (CME) Accreditation
The University of California San Diego School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category
1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
This CME activity meets the requirements under California Assembly Bill 1195, continuing education, and cultural linguistic
competency.
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity,
and scientific rigor. All persons involved in the selection, development and presentation of content are required to
disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational
activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship
with the commercial interest, 2) altering the individual’s control over CME content about the products or services
of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons
are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse
or fail to disclose will be disqualified from participating in the CME activity.
Continuing Education Credits (CEs)/ Contact Hours (CEHs)
The training course meets the qualifications for the provision of four (4.0) continuing education credits/ contact hours
(CEs/CEHs). UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing
education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course
and its content. Course meets the qualifications for four (4.0) hours of continuing education credit for LMFTs, LCSWs,
LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider
of continuing education for RADTs I/II, CADCsCASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1121), CATCs
(ACCBC/CAADE, #CP40 872 C 0822), and CAODCs (CADTP, #151). CE credit will be awarded six-eight weeks after the virtual
training. Partial credit will not be available for those participants who arrive late or leave early. Instructions
for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program: Please contact Dr. Thomas E. Freese, CE
Program Administrator, in writing (UCLA ISAP, 11075 Santa Monica Boulevard, Suite 200, Los Angeles, CA 90025) or by
phone (310- 267-5397).
